You have 9 free searches left this month | for more free features.

ibi110

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignancies Trial in Shanghai (IBI110, IBI110+ Sintilimab)

Recruiting
  • Advanced Malignancies
  • IBI110
  • IBI110+ Sintilimab
  • Shanghai, China
    Shanghai Pulmonary Hospital
Sep 13, 2022

SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

Active, not recruiting
  • SCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 18, 2022

NSCLC (NSCLC) Trial in Tianjin (IBI110, sintilimab)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Dec 26, 2021

DLBCL Trial in Shanghai (IBI110 plus sintilimab, IBI110)

Not yet recruiting
  • DLBCL
  • IBI110 plus sintilimab
  • IBI110
  • Shanghai, Shanghai, China
    Ruijin Hospital affiliated to Shanghai Jiao Tong University Scho
Sep 1, 2021